Latest News

Latest News

News from the World Hepatitis Alliance

WHA presents Tools For Change webinar series to enhance patient advocacy

27 Jan 2016 Bridie Taylor

Patient group advocacy has the power to effect real lasting change and improve the lives of millions living with viral hepatitis. We believe that...

Welcoming five new members to the World Hepatitis Alliance

26 Jan 2016 Bridie Taylor

This month, we welcome five new organisations to the World Hepatitis Alliance. Our alliance is now made up of 230 organisations in 81 countries in...

Hepatitis Testing Innovation Contest now open for submissions!

19 Jan 2016 Tara Farrell

Do you have a new and exciting idea on how to deliver hepatitis B and C testing? Be in with a chance to contribute to the 2016 WHO Hepatitis Testing...

World Hepatitis Day 2015 Summary Report released

19 Jan 2016 Bridie Taylor

On 28 July, World Hepatitis Day (WHD) brings the world together to raise awareness of the global burden of viral hepatitis and to influence real...

Public health experts, patients and policymakers convene at inaugural African Viral Hepatitis Summit to discuss the need for comprehensive national plans

19 Jan 2016 Tara Farrell

Today, more than 100 leading African and international public health experts, patient representatives, policymakers and physicians have gathered in...

Patient Solidarity Day: Uniting to declare healthcare a human right

3 Dec 2015 Bridie Taylor

On 5th December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that healthcare is a human right. Co-ordinated by...

Welcoming four new members

2 Dec 2015 Bridie Taylor

The World Hepatitis Alliance continues to grow as we welcome four new member organisations. Our membership is now made up of over 225 groups in 81...

HIV patients with viral hepatitis are three times more likely to have liver disease, liver failure and liver-related deaths

1 Dec 2015 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2015 -...

Innovative patent agreement shows success of patient advocacy

23 Nov 2015 Bridie Taylor

The World Hepatitis Alliance congratulates the Medicines Patent Pool (MPP) and Bristol – Myers Squibb (BMS) for recognising the global hepatitis...

Medicines Patent Pool expands its mandate to hepatitis C treatment

6 Nov 2015 Bridie Taylor

The World Hepatitis Alliance welcomes the recent announcement from the Medicines Patent Pool (MPP) that they will be expanding their mandate to...

The global hepatitis community unites to demand access to life-saving hepatitis treatment

2 Nov 2015 Bridie Taylor

London, 2 November 2015: Today the World Hepatitis Alliance launches an open letter calling for immediate action to vastly improve access to life-...

Webinar on the Global Movement to Eliminate Viral Hepatitis

27 Oct 2015 Bridie Taylor

Learn more about the global movement to eliminate viral hepatitis. On 28 th October WHA President Charles Gore and WHA Executive Board Member for the...

WHO Regional Committee meetings see regions commit to tackling viral hepatitis

23 Oct 2015 Bridie Taylor

Despite viral hepatitis impacting almost every country in the world, the burden differs significantly from region to region. In order to achieve...

Expanding the membership base of the World Hepatitis Alliance

1 Oct 2015 Bridie Taylor

The membership base of the World Hepatitis Alliance continues to go from strength to strength as we welcome five new organisations. Our membership is...

Looking ahead to the next Summit

17 Sep 2015 Bridie Taylor

Following the first World Hepatitis Summit that took place in Glasgow, Scotland 2-4 September, we are already looking ahead to the next Summit. The...

Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025

15 Sep 2015

By Keith Alcorn, Infohep.org Reaching the World Health Organization’s proposed targets for viral hepatitis control by 2030 could require global...

Medicines Patent Pool looks at hepatitis C

14 Sep 2015

By Keith Alcorn, Infohep.org Greg Perry, Executive Director of the Medicines Patent Pool, told delegates at the World Hepatitis Summit in Glasgow...

World Health Organization calls for ambitious global targets for viral hepatitis control

5 Sep 2015

By Keith Alcorn, Infohep.org The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of...

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit

4 Sep 2015 Bridie Taylor

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit Global leaders...

World Hepatitis Summit: New data shows relentless rise in hepatitis deaths

2 Sep 2015

New data shows relentless rise in hepatitis deaths: World leaders meet in Scotland to discuss urgent response and move towards elimination of 7th...

Pages

News from infohep

Immune modulator inarigivir looks promising for people with hepatitis B

12 Dec 2017 Liz Highleyman
Inarigivir, or SB 9200, an immune-modulating drug that has a dual mechanism of action against hepatitis B virus (HBV), reduced levels of HBV DNA, RNA...

TAF for hepatitis B improves kidney function and bone loss

30 Nov 2017 Liz Highleyman
Tenofovir alafenamide (TAF) remains effective against hepatitis B virus (HBV) for 96 weeks, with no resistance detected, according to studies...

REP 2139 combination therapy leads to functional control of hepatitis B virus

29 Nov 2017 Liz Highleyman
A majority of chronic hepatitis B patients treated with a nucleic acid polymer (REP 2139 or REP 2165) plus tenofovir and pegylated interferon were...

Sofosbuvir/ledipasvir for 8 weeks cures acute HCV in people with HIV

28 Nov 2017 Liz Highleyman
An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to a sustained response in all people with HIV and genotype 1 or 4 hepatitis C virus (HCV) in...

US approves new hepatitis B vaccine as public health agencies update guidelines

27 Nov 2017 Liz Highleyman
On 9 November the US Food and Drug Administration (FDA) approved Heplisav-B, a new vaccine that provides protection against all known subtypes of...

Model shows hepatitis C treatment is cost-effective in Japan

27 Nov 2017 Liz Highleyman
Treatment of chronic hepatitis C with direct-acting antivirals (DAAs) can lead to substantial savings by preventing the development of liver failure...

More work and lower drug prices are needed to eliminate hepatitis C worldwide

27 Nov 2017 Liz Highleyman
Eliminating hepatitis C virus (HCV) as a global public health concern is feasible, but to do this more people need to be tested and treated and...

Nivolumab improves outcomes in liver cancer study

13 Nov 2017 Liz Highleyman
Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumour size or disease...

High rate of hepatitis C reinfection in German men who have sex with men

3 Nov 2017 Keith Alcorn
Around one in seven gay and bisexual men cured of hepatitis C at major treatment centres in Germany has become reinfected since 2014, according to...

Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis

2 Nov 2017 Keith Alcorn
Nine countries – Australia, Brazil, Egypt, Georgia, Germany, Iceland, Japan, the Netherlands and Qatar – are on course to eliminate hepatitis C by...